Literature DB >> 20456485

Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.

Helen H Wang1, Frank Lammert, Anne Schmitz, David Q-H Wang.   

Abstract

BACKGROUND: Cholesterol gallstone disease is a complex genetic trait and induced by multiple but as yet unknown genes. A major Lith gene, Lith1 was first identified on chromosome 2 in gallstone-susceptible C57L mice compared with resistant AKR mice. Abcb11, encoding the canalicular bile salt export pump in the hepatocyte, co-localizes with the Lith1 QTL region and its hepatic expression is significantly higher in C57L mice than in AKR mice.
MATERIAL AND METHODS: To investigate whether Abcb11 influences cholesterol gallstone formation, we created an Abcb11 transgenic strain on the AKR genetic background and fed these mice with a lithogenic diet for 56 days. RESULT: We excluded functionally relevant polymorphisms of the Abcb11 gene and its promoter region between C57L and AKR mice. Overexpression of Abcb11 significantly promoted biliary bile salt secretion and increased circulating bile salt pool size and bile salt-dependent bile flow rate. However, biliary cholesterol and phospholipid secretion, as well as gallbladder size and contractility were comparable in transgenic and wild-type mice. At 56 days on the lithogenic diet, cholesterol saturation indexes of gallbladder biles and gallstone prevalence rates were essentially similar in these two groups of mice.
CONCLUSION: Overexpression of Abcb11 augments biliary bile salt secretion, but does not affect cholelithogenesis in mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456485      PMCID: PMC2929639          DOI: 10.1111/j.1365-2362.2010.02300.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  48 in total

1.  Promoter of the gene encoding the 16 kDa DNA-binding and apoptosis-inducing C1D protein.

Authors:  K Rothbarth; A Hunziker; H Stammer; D Werner
Journal:  Biochim Biophys Acta       Date:  2001-04-16

2.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.

Authors:  K E Berge; H Tian; G A Graf; L Yu; N V Grishin; J Schultz; P Kwiterovich; B Shan; R Barnes; H H Hobbs
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice.

Authors:  D Q Wang; B Paigen; M C Carey
Journal:  J Lipid Res       Date:  2001-11       Impact factor: 5.922

Review 4.  Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map.

Authors:  F Lammert; M C Carey; B Paigen
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

5.  MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.

Authors:  O Rosmorduc; B Hermelin; R Poupon
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

6.  Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies.

Authors:  David Q-H Wang; Martin C Carey
Journal:  J Lipid Res       Date:  2003-02-16       Impact factor: 5.922

7.  Mechanisms for increased expression of cholesterol 7alpha-hydroxylase (Cyp7a1) in lactating rats.

Authors:  Clavia Ruth Wooton-Kee; Donna J Coy; Antony T Athippozhy; Tianyong Zhao; Brett R Jones; Mary Vore
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

8.  Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.

Authors:  Liqing Yu; Jia Li-Hawkins; Robert E Hammer; Knut E Berge; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk.

Authors:  Guylaine Bouchard; Derek Johnson; Tonya Carver; Beverly Paigen; Martin C Carey
Journal:  J Lipid Res       Date:  2002-07       Impact factor: 5.922

10.  Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.

Authors:  R Wang; M Salem; I M Yousef; B Tuchweber; P Lam; S J Childs; C D Helgason; C Ackerley; M J Phillips; V Ling
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  9 in total

1.  Puerariae flos alleviates metabolic diseases in Western diet-loaded, spontaneously obese type 2 diabetic model mice.

Authors:  Koshi Kubo; Tsutomu Shimada; Rei Onishi; Masahito Tsubata; Tomoyasu Kamiya; Rika Nagamine; Seiichi Iizuka; Yoshimichi Sai; Sakae Amagaya; Masaki Aburada; Ken-ichi Miyamoto
Journal:  J Nat Med       Date:  2012-02-16       Impact factor: 2.343

2.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

3.  Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

Authors:  Anne S Henkel; Mark H Kavesh; Michael S Kriss; Amanda M Dewey; Mary E Rinella; Richard M Green
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

Review 4.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Biliary cholesterol secretion: more than a simple ABC.

Authors:  Arne Dikkers; Uwe-Jf Tietge
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

6.  Enhancement of interaction of BSEP and HAX-1 on the canalicular membrane of hepatocytes in a mouse model of cholesterol cholelithiasis.

Authors:  Jing Kong; Bin-Bin Liu; Shuo-Dong Wu; Yu Wang; Qing-Quan Jiang; En-Ling Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 7.  Clinical application of transcriptional activators of bile salt transporters.

Authors:  Anna Baghdasaryan; Peter Chiba; Michael Trauner
Journal:  Mol Aspects Med       Date:  2013-12-12

8.  The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism.

Authors:  Egon Demetz; Andrea Schroll; Kristina Auer; Christiane Heim; Josef R Patsch; Philipp Eller; Markus Theurl; Igor Theurl; Milan Theurl; Markus Seifert; Daniela Lener; Ursula Stanzl; David Haschka; Malte Asshoff; Stefanie Dichtl; Manfred Nairz; Eva Huber; Martin Stadlinger; Alexander R Moschen; Xiaorong Li; Petra Pallweber; Hubert Scharnagl; Tatjana Stojakovic; Winfried März; Marcus E Kleber; Katia Garlaschelli; Patrizia Uboldi; Alberico L Catapano; Frans Stellaard; Mats Rudling; Keiji Kuba; Yumiko Imai; Makoto Arita; John D Schuetz; Peter P Pramstaller; Uwe J F Tietge; Michael Trauner; Giuseppe D Norata; Thierry Claudel; Andrew A Hicks; Guenter Weiss; Ivan Tancevski
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

9.  The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.

Authors:  Ning Fan; Ke Meng; Yuqing Zhang; Yong Hu; Donghua Li; Qiaoying Gao; Jianhua Wang; Yanning Li; Shangwei Wu; Yunfeng Cui
Journal:  Lipids Health Dis       Date:  2020-07-02       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.